Advertisement

Topics

Latest "Auxilium" News Stories

09:54 EDT 16th August 2018 | BioPortfolio

Here are the most relevant search results for "Auxilium" found in our extensive news archives from over 250 global news sources.

More Information about Auxilium on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Auxilium for you to read. Along with our medical data and news we also list Auxilium Clinical Trials, which are updated daily. BioPortfolio also has a large database of Auxilium Companies for you to search.

Showing "Auxilium" News Articles, all 4

Relevant

Endo Announces Master Settlement Agreement Allowing for Resolution of Known Testosterone Replacement Therapy Product Liability Claims and Entry of Significant Case Management Order

DUBLIN, June 11, 2018 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) today announced that its subsidiaries Endo Pharmaceuticals Inc. and Auxilium Pharmaceuticals, LLC (collectively, "Endo" ...


Probably Relevant

BioSpecifics Technologies Corp BSTC Financial and Strategic SWOT Analysis Review [Report Updated: 30052018] Prices from USD $125

BioSpecifics Technologies Corp BSTC Financial and Strategic SWOT Analysis Review provides you an indepth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies tha...

Tmunity Appoints Jason Krentz as Chief Technology Officer and Head of Technical Operations

Tmunity Therapeutics, Inc., a private clinical-stage biotherapeutics company focused on saving and improving lives by delivering the full potential of next-generation T cell immunotherapy, today announced the appointment of Jason Krentz as Chief Technology Officer and Head of Technical Operations. Mr. Krentz formerly served in manufacturing and technical o...


Kala Pharmaceuticals Appoints Eric Trachtenberg as General Counsel and Corporate Secretary

Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the development and commercialization of product candidates using its proprietary mucus-penetrating particle (MPP) technology, today announced the appointment of Eric Trachtenberg as General Counsel and Corporate Secretary. “I am thrilled to announce Eric’s appoin...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks